Scarica l'app Stockscreener
186.56
1.41%
2.0417
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$184.52
Aprire:
$184.44
Volume 24 ore:
24,449
Relative Volume:
0.11
Capitalizzazione di mercato:
$3.65B
Reddito:
$152.42M
Utile/perdita netta:
$45.24M
Rapporto P/E:
74.33
EPS:
2.51
Flusso di cassa netto:
$6.97M
1 W Prestazione:
+1.01%
1M Prestazione:
+5.64%
6M Prestazione:
+70.33%
1 anno Prestazione:
+70.41%
Intervallo 1D:
$184.44
$188.77
Intervallo di 1 settimana:
$182.87
$194.44
Portata 52W:
$93.58
$194.44
Ligand Pharmaceuticals Inc Stock (LGND) Company Profile
Nome
Ligand Pharmaceuticals Inc
Settore
Industria
Telefono
858-550-7500
Indirizzo
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
Confronta LGND con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LGND
Ligand Pharmaceuticals Inc
|
186.50 | 3.60B | 152.42M | 45.24M | 6.97M | 2.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.16 | 106.97B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
659.01 | 68.62B | 14.25B | 4.58B | 3.56B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.41 | 63.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
804.06 | 50.61B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.27 | 35.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Ligand Pharmaceuticals Inc Stock (LGND) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-10 | Iniziato | Stifel | Buy |
| 2024-10-03 | Iniziato | Oppenheimer | Outperform |
| 2024-07-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-04-14 | Ripresa | Stephens | Overweight |
| 2021-02-04 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-06 | Iniziato | Barclays | Overweight |
| 2020-03-24 | Downgrade | Argus | Buy → Hold |
| 2020-03-10 | Iniziato | Guggenheim | Neutral |
| 2020-02-06 | Iniziato | The Benchmark Company | Buy |
| 2019-09-19 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2019-06-11 | Iniziato | Barclays | Equal Weight |
| 2019-05-03 | Reiterato | H.C. Wainwright | Buy |
| 2019-03-06 | Reiterato | H.C. Wainwright | Buy |
| 2018-10-29 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2018-10-02 | Reiterato | H.C. Wainwright | Buy |
| 2018-09-11 | Reiterato | Argus | Buy |
| 2018-08-17 | Iniziato | Goldman | Neutral |
| 2018-08-08 | Downgrade | ROTH Capital | Buy → Neutral |
| 2018-06-21 | Iniziato | Argus | Buy |
| 2017-12-27 | Reiterato | H.C. Wainwright | Buy |
| 2017-09-05 | Ripresa | H.C. Wainwright | Buy |
| 2016-10-05 | Reiterato | H.C. Wainwright | Buy |
| 2016-08-05 | Downgrade | Deutsche Bank | Hold → Sell |
| 2016-03-11 | Iniziato | Sidoti | Buy |
| 2016-03-03 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Ligand Pharmaceuticals Inc Borsa (LGND) Ultime notizie
Intraday pattern recognizer results for Ligand Pharmaceuticals IncorporatedWeekly Loss Report & Precise Swing Trade Entry Alerts - newser.com
Ligand Pharmaceuticals (LGND) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Will Ligand Pharmaceuticals Incorporated outperform the marketJuly 2025 Retail & Weekly High Return Stock Opportunities - newser.com
Will Ligand Pharmaceuticals Incorporated (LGDN) stock announce a stock splitWeekly Profit Report & Community Verified Trade Signals - newser.com
Short interest data insights for Ligand Pharmaceuticals IncorporatedMarket Performance Report & Growth Focused Investment Plans - newser.com
What institutional flow reveals about Ligand Pharmaceuticals IncorporatedChart Signals & High Conviction Buy Zone Picks - newser.com
Is Ligand Pharmaceuticals Incorporated forming a reversal patternMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com
Ligand Pharmaceuticals IncorporatedEquity Right (LGNZZ) Price Target Decreased by 44.49% to 0.08 - Nasdaq
Ligand Pharmaceuticals Reaches Analyst Target Price - Nasdaq
Is Ligand Pharmaceuticals Incorporated (LGDN) stock attractive post correctionStock Surge & Free High Accuracy Swing Entry Alerts - newser.com
What catalysts could drive Ligand Pharmaceuticals Incorporated stock higherPortfolio Value Report & Low Risk High Win Rate Stock Picks - newser.com
Can Ligand Pharmaceuticals Incorporated stock sustain market leadership2025 Market Overview & Weekly High Return Opportunities - newser.com
What analyst consensus says on Ligand Pharmaceuticals Incorporated stockWeekly Risk Summary & Free Daily Entry Point Trade Alerts - newser.com
Can technical indicators confirm Ligand Pharmaceuticals Incorporated’s reversalQuarterly Market Review & Community Consensus Trade Signals - newser.com
Why Ligand Pharmaceuticals Incorporated stock is a value investor pickJuly 2025 Chart Watch & Real-Time Stock Entry Alerts - Fundação Cultural do Pará
How to use Fibonacci retracement on Ligand Pharmaceuticals IncorporatedQuarterly Profit Review & Verified Momentum Watchlists - newser.com
Technical signs of recovery in Ligand Pharmaceuticals IncorporatedPortfolio Update Summary & Verified High Yield Trade Plans - newser.com
Is Ligand Pharmaceuticals Incorporated reversing from oversold territoryStop Loss & Intraday High Probability Setup Alerts - newser.com
Does Ligand Pharmaceuticals Incorporated show high probability of reboundJuly 2025 Review & Weekly High Potential Alerts - newser.com
Published on: 2025-10-28 01:03:19 - newser.com
How Ligand Pharmaceuticals Incorporated (LGDN) stock compares with market leadersCPI Data & Daily Oversold Bounce Ideas - newser.com
Analyzing drawdowns of Ligand Pharmaceuticals Incorporated with statistical tools2025 Macro Impact & Low Risk Entry Point Tips - newser.com
Ligand Pharmaceuticals Incorporated stock daily chart insightsWeekly Profit Report & Community Driven Trade Alerts - newser.com
Price action breakdown for Ligand Pharmaceuticals IncorporatedJuly 2025 Summary & Daily Stock Trend Reports - newser.com
Chart overlay techniques for tracking Ligand Pharmaceuticals IncorporatedWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com
Ligand Pharmaceuticals Inc Azioni (LGND) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
1.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):